lipoxin a4 has been researched along with Pneumonia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bataille, F; Colas, C; Couturier-Maillard, A; Dumoutier, L; Fauconnier, L; Maillet, I; Michaudel, C; Quesniaux, VF; Ryffel, B; Sokol, H; Straube, M; Togbe, D; van Snick, J | 1 |
| Norling, LV; Perretti, M | 1 |
| Andonegui, G; Biernaskie, J; Granton, E; Hiroki, CH; Kim, JH; Labit, E; Lou, Y; Podstawka, J; Rosin, NL; Sarden, N; Sheppard, DC; Sinha, S; Snarr, BD; Yipp, BG | 1 |
| Bahl, CD; Bomberger, JM; Dolben, E; Flitter, BA; Hampton, TH; Hogan, DA; Hvorecny, KL; Levy, BD; Madden, DR; Moreau-Marquis, S; Shabaneh, TB; Stanton, BA | 1 |
| Gao, Z; Jiang, Y; Li, L; Pan, M; Su, EM; Su, X; Sun, P; Sun, W; Wu, H; Yang, J; Yang, X; Zhao, C | 1 |
| Buret, AG; Duquette, SC; Feener, TD; Fischer, CD; Hollenberg, MD; Lucas, MJ; Morck, DW; Renaux, BS | 1 |
| Allen, MJ; Beckham, Y; Birukov, KG; Birukova, AA; Gardel, ML; Leff, A; Mambetsariev, I; Meliton, A; Meng, F; Tian, Y | 1 |
| Cai, XH; Chen, J; Gao Smith, F; Gao, Y; Gu, JQ; Hao, Y; Jin, SW; Jin, XG; Li, H; Meng, J; Qi, W; Tang, Q; Wen, AQ; Xie, HQ; Xue, XY; Zhang, JL | 1 |
| Croze, R; Levy, BD; Pfeffer, MA; Planagumà, A; Rubin, G; Serhan, CN; Uddin, M | 1 |
| Anderson, GP; Bozinovski, S; Hutchinson, A; Irving, LB; Levy, BD; McQualter, JL; Merritt, AS; Thompson, M; Uddin, M; Vlahos, R; Wark, PA | 1 |
| Bonnans, C; Bousquet, J; Chanez, P; Chavis, C; Farce, M; Godard, P; Vachier, I | 1 |
11 other study(ies) available for lipoxin a4 and Pneumonia
| Article | Year |
|---|---|
Ozone-Induced Aryl Hydrocarbon Receptor Activation Controls Lung Inflammation via Interleukin-22 Modulation.
Topics: Animals; Antibodies, Neutralizing; Basic Helix-Loop-Helix Transcription Factors; CD4-Positive T-Lymphocytes; Interleukin-17; Interleukin-22; Interleukins; Lipoxins; Lung Injury; Mice; Mice, Inbred C57BL; Mice, Knockout; Ozone; Pneumonia; Receptors, Aryl Hydrocarbon; Receptors, Interleukin-17; Respiratory Hypersensitivity; Tryptophan | 2020 |
Proresolving lipid mediators enhance PMN-mediated bacterial clearance.
Topics: Humans; Lipoxins; Neutrophils; Phagocytosis; Pneumonia; Toll-Like Receptor 9 | 2020 |
Marginating transitional B cells modulate neutrophils in the lung during inflammation and pneumonia.
Topics: Animals; Aspergillosis; B-Lymphocytes; Capillaries; Cell Adhesion; Chemokine CXCL13; Integrin alpha5; Intravital Microscopy; Lipoxins; Lung; Mice, Mutant Strains; Neutrophils; Pneumonia; Receptors, CXCR5; Single-Cell Analysis | 2021 |
An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung.
Topics: Animals; Bacterial Proteins; Biological Transport; Bronchi; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Humans; Lipoxins; Male; Mice; Mice, Inbred C57BL; Mucociliary Clearance; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2018 |
Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice.
Topics: Animals; Bronchoalveolar Lavage; Chemokine CXCL2; Cystic Fibrosis Transmembrane Conductance Regulator; Escherichia coli; Lipopolysaccharides; Lipoxins; Mice, Inbred CFTR; Mutation; P-Selectin; Platelet Activating Factor; Platelet Count; Pneumonia; Thrombocytopenia | 2014 |
Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Calcimycin; Cattle; Dinoprostone; Disaccharides; Heterocyclic Compounds; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxins; Lung; Male; Neutrophils; Particulate Matter; Phospholipases A2; Pneumonia; Primary Cell Culture; Zymosan | 2014 |
Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Humans; Interleukin-8; Lipopolysaccharides; Lipoxins; Lung Injury; Mice, Inbred C57BL; Pneumonia; Signal Transduction | 2015 |
Lipoxin A4 activates alveolar epithelial sodium channel gamma via the microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced inflammatory lung injury.
Topics: Animals; Cell Line; Down-Regulation; Epithelial Sodium Channels; Lipopolysaccharides; Lipoxins; Male; MicroRNAs; Pneumonia; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Up-Regulation | 2015 |
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Disease; Animals; Anticholesteremic Agents; Cell Line; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Inflammation; Inflammation Mediators; Lipoxins; Lovastatin; Male; Mice; Neutrophils; Pneumonia; Respiratory Mucosa | 2010 |
Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease.
Topics: Animals; Bronchoalveolar Lavage Fluid; Epithelial Cells; Epithelium; Glucocorticoids; Humans; Interleukin-8; Lipoxins; Lung; Macrophages; Mice; Mucous Membrane; Neutrophil Activation; Neutrophils; Pneumonia; Pulmonary Disease, Chronic Obstructive; Receptors, Formyl Peptide; Receptors, Lipoxin; Serum Amyloid A Protein | 2012 |
Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound.
Topics: Adult; Asthma; Female; Humans; Interleukin-8; Leukotriene B4; Lipoxins; Male; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Sputum | 2005 |